Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Darras

Showing results (271-280 of 303) with videos related to

Pageof 31
Sort By:
Pediatric Physical Therapy : the Official Publication of the Section on Pediatrics of the American Physical Therapy Association|June 21, 2018
Quantitative Evaluation of Lower Extremity Joint Contractures in Spinal Muscular Atrophy: Implications for Motor FunctionRachel Salazar, Jacqueline Montes, Sally Dunaway Young, et al.
Neuromuscular Disorders : NMD|June 27, 2024
Changes in abilities over the initial 12 months of nusinersen treatment for type II SMAGiorgia Coratti, Matthew Civitello, Annemarie Rohwer, et al.
Neurology. Clinical Practice|December 18, 2023
Life-Saving Treatments for Spinal Muscular Atrophy: Global Access and AvailabilityVictor D Armengol, Basil T Darras, Ahmad A Abulaban, et al.
Neurology|October 17, 2020
Respiratory Trajectories in Type 2 and 3 Spinal Muscular Atrophy in the iSMAC Cohort StudyFederica Trucco, Deborah Ridout, Mariacristina Scoto, et al.
Annals of Clinical and Translational Neurology|June 24, 2021
Nusinersen in pediatric and adult patients with type III spinal muscular atrophyMaria Carmela Pera, Giorgia Coratti, Francesca Bovis, et al.
Journal of Clinical Medicine|March 11, 2023
2-Year Change in Revised Hammersmith Scale Scores in a Large Cohort of Untreated Paediatric Type 2 and 3 SMA ParticipantsGeorgia Stimpson, Danielle Ramsey, Amy Wolfe, et al.
Neurology|October 19, 2012
Prospective cohort study of spinal muscular atrophy types 2 and 3Petra Kaufmann, Michael P McDermott, Basil T Darras, et al.
Orphanet Journal of Rare Diseases|October 22, 2025
Differences in swallowing efficacy of disease modifying treatment between infants receiving pre-symptomatic and symptomatic administrationKatlyn Elizabeth McGrattan, Alicia Hofelich Mohr, Anna Miles, et al.
European Journal of Neurology|April 24, 2024
Determining minimal clinically important differences in the Hammersmith Functional Motor Scale Expanded for untreated spinal muscular atrophy patients: An international studyGiorgia Coratti, Francesca Bovis, Maria Carmela Pera, et al.
Neuromuscular Disorders : NMD|September 19, 2024
Upper limb function changes over 12 months in untreated SMA II and III individuals: an item-level analysis using the Revised Upper Limb ModuleGiorgia Coratti, Matthew Civitello, Annemarie Rohwer, et al.
Pageof 31

Showing results (271-280 of 303) with videos related to

Sort By:
Pageof 31
Pediatric Physical Therapy : the Official Publication of the Section on Pediatrics of the American Physical Therapy Association|June 21, 2018
Quantitative Evaluation of Lower Extremity Joint Contractures in Spinal Muscular Atrophy: Implications for Motor FunctionRachel Salazar, Jacqueline Montes, Sally Dunaway Young, et al.
Neuromuscular Disorders : NMD|June 27, 2024
Changes in abilities over the initial 12 months of nusinersen treatment for type II SMAGiorgia Coratti, Matthew Civitello, Annemarie Rohwer, et al.
Neurology. Clinical Practice|December 18, 2023
Life-Saving Treatments for Spinal Muscular Atrophy: Global Access and AvailabilityVictor D Armengol, Basil T Darras, Ahmad A Abulaban, et al.
Neurology|October 17, 2020
Respiratory Trajectories in Type 2 and 3 Spinal Muscular Atrophy in the iSMAC Cohort StudyFederica Trucco, Deborah Ridout, Mariacristina Scoto, et al.
Annals of Clinical and Translational Neurology|June 24, 2021
Nusinersen in pediatric and adult patients with type III spinal muscular atrophyMaria Carmela Pera, Giorgia Coratti, Francesca Bovis, et al.
Journal of Clinical Medicine|March 11, 2023
2-Year Change in Revised Hammersmith Scale Scores in a Large Cohort of Untreated Paediatric Type 2 and 3 SMA ParticipantsGeorgia Stimpson, Danielle Ramsey, Amy Wolfe, et al.
Neurology|October 19, 2012
Prospective cohort study of spinal muscular atrophy types 2 and 3Petra Kaufmann, Michael P McDermott, Basil T Darras, et al.
Orphanet Journal of Rare Diseases|October 22, 2025
Differences in swallowing efficacy of disease modifying treatment between infants receiving pre-symptomatic and symptomatic administrationKatlyn Elizabeth McGrattan, Alicia Hofelich Mohr, Anna Miles, et al.
European Journal of Neurology|April 24, 2024
Determining minimal clinically important differences in the Hammersmith Functional Motor Scale Expanded for untreated spinal muscular atrophy patients: An international studyGiorgia Coratti, Francesca Bovis, Maria Carmela Pera, et al.
Neuromuscular Disorders : NMD|September 19, 2024
Upper limb function changes over 12 months in untreated SMA II and III individuals: an item-level analysis using the Revised Upper Limb ModuleGiorgia Coratti, Matthew Civitello, Annemarie Rohwer, et al.
Pageof 31